U.S. Sleep Aids Market Now Worth $28 Billion

April 6, 2018…  Marketdata Enterprises, Inc., a leading independent market research publisher of “off-the-shelf” studies about service industries since 1979, has released a new 175-page report entitled:  The U.S. Sleep Market.  This new Marketdata study examines the “sleep” market and its components, covering markets for: anti-insomnia medications (OTC & prescription), sleep labs, mattresses and pillows, CPAPs (continuous positive airway pressure devices) for sleep apnea, and retail sleep aids (earplugs, sleep lamps, sound machines, eye masks, books, and smartphone apps).
 
According to Research Director, John LaRosa: “As obesity rates climb and Americans age, more people are developing sleep apnea, restless leg syndrome and other sleep disorders. Plus, stressors related to the volatile stock market, terrorism, mass shootings, healthcare,  student debt, and protests against politicians are all resulting in more sleepless nights. As a result, a huge industry has emerged to analyze and treat America’s insomniacs—sleep lab and home test devices, CPAP masks, premium mattresses and pillows, Rx and OTC sleep medications, apps, sound machines and more.”
 
Major Findings:

Market Size and Growth… Marketdata estimates that the U.S. sleep market was worth $28.6 billion in 2017. For 2018, the market should grow by 3.3%. To 2023, we forecast 4.7% average annual growth.

The prescription insomnia drugs market, led by Belsomra, Ambien, and Lunesta, has been declining in value due to the expiration of patents and the entry of cheaper generics. These drugs’ sales total about $1.4 billion. However, the non-prescription or OTC sleeping pills market, valued at $576 million, is growing faster.  

Sleep Labs - There are an estimated 4,700 U.S. sleep centers or labs which perform studies to diagnose sleep disorders. The typical lab has revenues of $920,000 and a bed count of about 7-8. Labs are located in hospitals, MD practices, universities, or are independent. This segment was worth $4.3 billion in 2017. There has been consolidation and closures due to reimbursement pressure from competing portable home testing devices approved by Medicare, but patient volumes are rising.

CPAP devices – This is a $4.3 billion market that’s growing 7.2% a year.  It is dominated by ResMed and Respironics.  The market is largely untapped – only 12% penetrated. It has major potential, as more people, especially the obese, are being diagnosed with obstructive sleep apnea.

The huge $16 billion mattress market is undergoing transformation, as technology changes the materials mattresses are made of, and the major retailers merge. E-commerce upstarts such as Casper have revolutionized how consumers purchase mattresses—online and delivered direct out of a box. Premium non-innerspring (air, memory foam) models are selling well.

The sleep pillows market is worth $1.6 billion and is also growing, as new materials and premium-priced pillows enter the market.

Retail devices generate about $200 million in sales—for: earplugs, light therapy machines, sound conditioning machines, books about sleep advice, sleep pods, eye masks, smartphone apps, and other devices.
 

According to Research Director, John LaRosa: “An estimated 70 million Americans have insomnia, and 43 million suffer from obstructive sleep apnea (OSA), mostly undiagnosed. As obesity rates remain high, this problem is not likely to dissipate any time soon. Therefore, there is ample room for future growth of CPAP devices, sleep studies, OTC and prescription medications and other services.”
 
 
Editor’s Note: The  U.S. Sleep Market , published in April 2018, is an independently researched  market  research study.  It contains 43 tables, 16 competitor profiles, and is 175 pages long.  It costs $1,495, but is sold by individual chapters at lower cost.  A free brochure is available by mail, Fax, or email:  Contact:  John LaRosa, Marketdata Enterprises, Inc., 7210 Wareham Drive, Tampa, FL 33647, 813-971-8080, or: see the website: www.marketdataenterprises.com.   A 27 pp. Overview of report highlights is available to the general public for $99.

Contact Information

John LaRosa

Research Director

Marketdata LLC

(1) 813-971-8080

marketdataent@yahoo.com